The Centers for Medicare & Medicaid Services has revised the way Medicare administrative contractors make local coverage determinations for medical technologies, as required by the 21st Century Cures Act to promote transparency. Among other changes, the updated process expands who can participate on the contractor advisory committees that inform LCDs, opens CAC meetings to the public and requires a standardized summary of the clinical evidence supporting an LCD decision. CMS said the changes, published as an update to the Medicare Program Integrity Manual, will clarify and simplify the LCD process so that companies can get therapies and devices to patients more efficiently.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models. The first proposed…
Headline
The White House announced Dec. 19 that it reached most-favored-nation deals with nine pharmaceutical companies, aligning their drug prices with the lowest paid…
Headline
The House Dec. 17 passed the Lower Health Care Premiums for All Americans Act (H.R. 6703), legislation to expand association health plans, increase…
Headline
The AHA Dec. 17 urged Elevance Health, which is the parent company of the Anthem brand of health plans, to rescind Anthem’s nonparticipating provider…
Headline
The Centers for Medicare & Medicaid Services released a memo Dec. 16 announcing the agency’s intent to conduct a voluntary pilot in 2026, called the…
Headline
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.  “When…